Skip to main content
Figure 3 | Diagnostic Pathology

Figure 3

From: Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma

Figure 3

Cumulative disease-free survival rates of patients according to presence of SMPC and AMPC. A, B are cumulative disease-free survival rates in all stage, and C, D are that of in p-stage I. Cumulative disease-free survival rates stratified by presence of SMPC are shown in A and C, and those stratified by presence of AMPC are shown in B and D. In all stage and in p-stage I, SMPC(+) tumors and AMPC(+) tumors had significantly poorer outcomes. Outcomes of SMPC(+) tumors were more significantly negative than those of AMPC(+) tumors. SMPC, stromal micropapillary component; AMPC, aerogenous micropapillary component.

Back to article page